Intrabio Inc
Clinical trials sponsored by Intrabio Inc, explained in plain language.
-
New hope for rare disease: expanded access to experimental drug for A-T patients
Disease control AVAILABLEThis program provides an experimental drug, levacetylleucine, to people with Ataxia-Telangiectasia (A-T), a rare and serious genetic disease with no approved treatments. It is for patients who cannot join clinical trials and have no other good options. The goal is to offer potent…
Sponsor: IntraBio Inc • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New hope for rare brain disease as Final-Stage drug trial begins
Disease control Recruiting nowThis study is testing an investigational drug called N-Acetyl-L-Leucine (IB1001) to see if it can help control symptoms and improve daily function for people with Niemann-Pick disease type C (NPC), a rare and serious genetic disorder. It is a Phase 3 trial, meaning it's in the fi…
Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC